Body-fluid Balance and Drinking Habits in Patients With Retinal Vascular Occlusion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the body-fluid balance in patients with retinal vascular occlusion and the influence of drinking habits and hemodilution on the degree of body hydration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with retinal vascular occlusion who are hospitalized for hemodilution and cardiovascular risk assessment are asked to report their drinking habits. Hydration status before and during hemodilution is assessed with a body-fluid analyzing scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dehydration Retinal Vascular Occlusion

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

retinal vascular occlusion drinking habits body hydration body-fluid balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

retinal vascular occlusion

Patients with retinal vascular occlusion undergo a hematocrit dependent 5 day hemodilution

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* informed consent
* age over 18 years

Exclusion Criteria

* age under 18 years
* hypertensive urgency
* myocardial infarction \< 4 weeks ago, chest pain
* heart rhythm disorders, high degree valvular defects
* pacemaker, defibrillator
* peripheral arterial occlusive disease
* end stage renal disease
* acute hepatitis, chronic inflammatory intestinal disease
* pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. med. Evelyn Voigt

Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lutz E Pillunat, MD

Role: STUDY_DIRECTOR

University Eye Clinic Dresden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Eye Clinic

Dresden, Germany/ Saxony, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Evelyn Voigt, MD

Role: CONTACT

Phone: 00493514583381

Email: [email protected]

Karin Pillunat, MD